Are you a UK healthcare professional?

Yes No

Agenda

These promotional, multidisciplinary meetings are organised and funded by Celltrion Healthcare UK Ltd and intended for UK Healthcare professionals only. Celltrion products will be discussed. AE reporting and prescribing information for Omlyclo®▼ (omalizumab) can be accessed here: 75mg and 150mg. 

Arrival and registration will take place from 17.00, with buffet food and refreshments available for attendees prior to talks beginning at 17.30. This meeting will finish at 20:30.

Speaker

Session Title & Content

Duration

Local Speaker

Welcome & introduction*

  • Housekeeping
  • Meeting aim and learning objectives
  • Overview of agenda
  • Introduction to speakers

5 mins

Prof. Atholl Johnston

Understanding biosimilars – Part 1: a refresh on biosimilars*

  • What is a biosimilar?
  • Overview of the approval process and how it differs from originator biologics
    • Extrapolation of data in biosimilars approval
  • Patient considerations and communication
  • Biosimilars in practice – a case study from other practice – what does it mean to have biosimilar medications available in practice?
  • Topic Q&A

45 mins

Break 

  

10 mins

Dr Clive Grattan

Understanding biosimilars – Part 2: Overview of Omlyclo® ▼ (omalizumab)*

  • Summary of available evidence base to date
    • Licensed indications in CSU
    • Efficacy and biosimilarity
    • Safety – including immunogenicity
    • Extrapolation of data
  • Licensed respiratory indications for Omlyclo®
  • Expert experience of adoption and implementation
  • Topic Q&A

60 mins

Break

Opportunity for dermatologists to leave ahead of respiratory-specific session

10 mins

Dr Ian Clifton (Leeds)

or

Prof. Ratko Djukanovic (Southampton)

or

Dr Pujan Patel (London)

Allergic asthma in focus: local burden & treatment landscape‡

  • Topline refresh on the mechanisms underlying disease pathology in allergic asthma – role of IgE and immune cells
  • Brief overview of current treatments for allergic asthma and implications of recent advances
  • Summary of local landscape, including local challenges
  • Topic Q&A

30 mins

Panel

Q&A – final questions

10 mins

Local Speaker

Closing remarks

5 mins

*Session relevant to attendees with an interest in respiratory or dermatology care.

‡Session relevant to attendees with an interest in respiratory care only. There is an opportunity for healthcare professionals who are not focused on respiratory care to leave the meeting ahead of this session.

Speakers

National Speakers

Dr Clive Grattan
Dr Clive Grattan
Consultant Dermatologist, St John's Institute of Dermatology, Guy's and St Thomas' Hospital, London
Prof. Atholl Johnston
Prof. Atholl Johnston
Professor Emeritus of Clinical Pharmacology; Barts and The London School of Medicine and Dentistry; Queen Mary University of London

Local Speakers

Dr Ian Clifton
Dr Ian Clifton
Consultant in Respiratory Medicine; Leeds Teaching Hospitals NHS Trust
Prof. Ratko Djukanovic
Prof. Ratko Djukanovic
Professor of Medicine; University of Southampton
Dr Pujan Patel
Dr Pujan Patel
Consultant Respiratory Physician, Royal Brompton and Harefield Hospital

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or by searching for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Celltrion Healthcare UK Ltd. by emailing UKadverseevents@celltrionhc.com or calling +44 (0) 1753 983500.